ADVERTISEMENT
Manila Bulletin devider Philippines devider Vaccinated minors in Muntinlupa rise to 9,300

Vaccinated minors in Muntinlupa rise to 9,300

Published Nov 12, 2021 11:31 am

Minors aged 12 to 17 years old who received the first dose of the coronavirus disease (COVID-19) vaccine have reached more than 9,000.

According to the Muntinlupa City government, as of Nov. 11, a total of 9,301 minors with and without comorbidities were vaccinated in Muntinlupa.

A minor getting vaccinated against COVID-19 (Photo courtesy of Lady Ann Ebatan)

The total is equivalent to 17 percent of the estimated 55,391 population of 12 to 17 years old in Muntinlupa, rising from 5,648 vaccinated minors (10.2 percent of the total) recorded last Nov. 8.

The number of minors who have registered with the Muntinlupa City COVID-19 Vaccination Program (MunCoVac) also rose to 26,235 as of Nov. 11, or 47 percent of the total population of 12 to 17-year-olds, from 22,665 minors registered last Nov. 8, or 41 percent.

Of the 26,235 minor registrants, 2,117 (8.1 percent) have comorbidities, classified by the Department of Health (DOH) under Pediatric A3 group while 24,102 (91.9 percent) are “well children,” or those with no comorbidities.

According to MunCoVac, for minors without comorbidities, parents or guardians need to present a valid ID of the child, valid ID and proof of residency of the parent/guardian, proof of filiation such as birth certificate and vaccination card of the parent/guardian (if they are already vaccinated).

For minors with comorbidities, parents or guardians need to present a DOH medical certificate of the child, valid IDs of the child and parent/guardian, proof of filiation such as birth certificate and vaccination card of the parent/guardian (if they are already vaccinated).

Minors with comorbidities are vaccinated only at the city-run Ospital ng Muntinlupa. For “well children,” the vaccination sites in Muntinlupa are SM Center Muntinlupa, Ayala Malls South Park, New Cupang Health Center and Sucat covered court.

According to the DOH, comorbidities eligible for the Pediatric A3 vaccination are medical complexity, genetic conditions, neurologic conditions, metabolic/endocrine diseases, cardiovascular diseases, obesity, HIV infection, tuberculosis, chronic respiratory diseases, renal disorders, hepatobiliary diseases and immunocompromised state due to disease or treatment.

The two vaccines approved for use in people 12 years old and above in the country are Pfizer-BioNTech and Moderna.

Related Tags

MunCoVac Muntinlupa 12 to 17 years old vaccination Muntinlupa vaccination of minors Pediatric A3 PFIZER BIONTECH MODERNA VACCINE doh
ADVERTISEMENT
.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1561_widget.title }}

{{ item.title }}
.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1562_widget.title }}

{{ item.title }}
.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1563_widget.title }}

{{ item.title }}

{{ articles_filter_1564_widget.title }}

{{ item.title }}
.mb-article-details { position: relative; } .mb-article-details .article-body-preview, .mb-article-details .article-body-summary{ font-size: 17px; line-height: 30px; font-family: "Libre Caslon Text", serif; color: #000; } .mb-article-details .article-body-preview iframe , .mb-article-details .article-body-summary iframe{ width: 100%; margin: auto; } .read-more-background { background: linear-gradient(180deg, color(display-p3 1.000 1.000 1.000 / 0) 13.75%, color(display-p3 1.000 1.000 1.000 / 0.8) 30.79%, color(display-p3 1.000 1.000 1.000) 72.5%); position: absolute; height: 200px; width: 100%; bottom: 0; display: flex; justify-content: center; align-items: center; padding: 0; } .read-more-background a{ color: #000; } .read-more-btn { padding: 17px 45px; font-family: Inter; font-weight: 700; font-size: 18px; line-height: 16px; text-align: center; vertical-align: middle; border: 1px solid black; background-color: white; } .hidden { display: none; }
function initializeAllSwipers() { // Get all hidden inputs with cms_article_id document.querySelectorAll('[id^="cms_article_id_"]').forEach(function (input) { const cmsArticleId = input.value; const articleSelector = '#article-' + cmsArticleId + ' .body_images'; const swiperElement = document.querySelector(articleSelector); if (swiperElement && !swiperElement.classList.contains('swiper-initialized')) { new Swiper(articleSelector, { loop: true, pagination: false, navigation: { nextEl: '#article-' + cmsArticleId + ' .swiper-button-next', prevEl: '#article-' + cmsArticleId + ' .swiper-button-prev', }, }); } }); } setTimeout(initializeAllSwipers, 3000); const intersectionObserver = new IntersectionObserver( (entries) => { entries.forEach((entry) => { if (entry.isIntersecting) { const newUrl = entry.target.getAttribute("data-url"); if (newUrl) { history.pushState(null, null, newUrl); let article = entry.target; // Extract metadata const author = article.querySelector('.author-section').textContent.replace('By', '').trim(); const section = article.querySelector('.section-info ').textContent.replace(' ', ' '); const title = article.querySelector('.article-title h1').textContent; // Parse URL for Chartbeat path format const parsedUrl = new URL(newUrl, window.location.origin); const cleanUrl = parsedUrl.host + parsedUrl.pathname; // Update Chartbeat configuration if (typeof window._sf_async_config !== 'undefined') { window._sf_async_config.path = cleanUrl; window._sf_async_config.sections = section; window._sf_async_config.authors = author; } // Track virtual page view with Chartbeat if (typeof pSUPERFLY !== 'undefined' && typeof pSUPERFLY.virtualPage === 'function') { try { pSUPERFLY.virtualPage({ path: cleanUrl, title: title, sections: section, authors: author }); } catch (error) { console.error('ping error', error); } } // Optional: Update document title if (title && title !== document.title) { document.title = title; } } } }); }, { threshold: 0.1 } ); function showArticleBody(button) { const article = button.closest("article"); const summary = article.querySelector(".article-body-summary"); const body = article.querySelector(".article-body-preview"); const readMoreSection = article.querySelector(".read-more-background"); // Hide summary and read-more section summary.style.display = "none"; readMoreSection.style.display = "none"; // Show the full article body body.classList.remove("hidden"); } document.addEventListener("DOMContentLoaded", () => { let loadCount = 0; // Track how many times articles are loaded const offset = [1, 2, 3, 4, 5, 6, 7, 8, 9, 10]; // Offset values const currentUrl = window.location.pathname.substring(1); let isLoading = false; // Prevent multiple calls if (!currentUrl) { console.log("Current URL is invalid."); return; } const sentinel = document.getElementById("load-more-sentinel"); if (!sentinel) { console.log("Sentinel element not found."); return; } function isSentinelVisible() { const rect = sentinel.getBoundingClientRect(); return ( rect.top < window.innerHeight && rect.bottom >= 0 ); } function onScroll() { if (isLoading) return; if (isSentinelVisible()) { if (loadCount >= offset.length) { console.log("Maximum load attempts reached."); window.removeEventListener("scroll", onScroll); return; } isLoading = true; const currentOffset = offset[loadCount]; window.loadMoreItems().then(() => { let article = document.querySelector('#widget_1690 > div:nth-last-of-type(2) article'); intersectionObserver.observe(article) loadCount++; }).catch(error => { console.error("Error loading more items:", error); }).finally(() => { isLoading = false; }); } } window.addEventListener("scroll", onScroll); });
Join Our Newsletters

Sign up by email to receive news.

© 2025 Manila Bulletin The Nation's Leading Newspaper. All Rights Reserved.